Brighthouse Financial earnings missed by $1.34, revenue fell short of estimates

Brighthouse Financial (BHF) reported a significant miss on second-quarter financial results, with EPS of $3.14 falling $1.34 short of the $4.48 analyst estimate and revenue of $1.9 billion missing the $2.2 billion consensus. This substantial earnings and revenue shortfall follows seven negative EPS revisions in the past 90 days and has contributed to the stock's 7.61% decline over the last three months, despite a 4.77% gain over the past year.

Analysis

Brighthouse Financial (BHF) reported a significant second-quarter financial miss, with earnings per share of $3.14 falling approximately 30% short of the $4.48 analyst consensus. The company's revenue of $1.9 billion also failed to meet the $2.2 billion estimate, reinforcing the negative top-line and bottom-line performance. These disappointing results were preceded by a clear deterioration in analyst sentiment, as evidenced by seven negative EPS revisions and zero positive revisions over the past 90 days, suggesting that while a weaker quarter was anticipated, the magnitude of the miss was still substantial. The company's stock performance reflects this recent weakness, with a 7.61% decline over the last three months, which has eroded some of the 4.77% gain seen over the past year. The "fair performance" financial health score from InvestingPro suggests underlying fundamentals are adequate but provides little offset to the strongly negative sentiment from the current earnings report.

Key Decisions for Investors

• Investors should exercise caution, as the substantial miss on both Q2 revenue and EPS, coupled with a unanimous wave of negative analyst revisions, signals significant operational headwinds.
• Given the stock's recent 7.61% decline, it is prudent to monitor for further downward price momentum as the market fully digests these weaker-than-expected results.
• The lack of forward guidance in the report makes future management commentary critical; investors should watch for any updated outlook that could either confirm a negative trend or outline a path to recovery.